---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-026477"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-07-08T23:59:59+00:00"
generated_at: "2026-05-31T23:08:18.189421+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics secures $600K loan at 15% interest from Dennis Conklin

## Summary
- Loan agreement with Dennis R. Conklin for principal amount of $600,000.
- Note bears simple interest at 15% per annum, matures three years from July 2, 2024.
- Interest payable annually after each calendar year; principal and remaining interest due at maturity.
- Proceeds received on July 2, 2024; use of proceeds not specified.

## SEC filing metadata
- accession: 0001493152-24-026477
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-07-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224026477/0001493152-24-026477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224026477/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-026477
- JSON: https://secwatch.observer/filing/0001493152-24-026477.json
- Plain text: https://secwatch.observer/filing/0001493152-24-026477.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.